Bare Financial Services’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$900 Sell
36
-5
-12% -$141 ﹤0.01% 1300
2025
Q4
$1.29K Buy
41
+28
+215% +$929 ﹤0.01% 1023
2025
Q3
$464 Buy
+13
New +$594 ﹤0.01% 1339

Other funds holding PRCT

Bare Financial Services's PRCT Position: Q1 2026 in Review

Bare Financial Services reduced its Procept Biorobotics (PRCT) stake by 12% in Q1 2026, selling an estimated $141 and leaving 36 shares worth $900. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Bare Financial Services first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.29K in Q4 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Bare Financial Services held 36 shares of Procept Biorobotics worth $900 as of Q1 2026.
  • Bare Financial Services sold 5 Procept Biorobotics shares in Q1 2026, an estimated $141.
  • Procept Biorobotics made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #1300 holding.
  • Bare Financial Services first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • Bare Financial Services's Procept Biorobotics position peaked at $1.29K in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.